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Oxidative stress, excessive production of reactive oxygen species, is considered an important
part of different disorders, as well as of physiological processes (inflammation). The difference
between physiological and pathological oxidative stress is often the occurrence of lipid
peroxidation and its final toxic products, among which is 4-hydroxy-2-nonenal (HNE), a reac-
tive aldehyde that forms protein conjugates. The aim of this study was to determine the distri-
bution of HNE-histidine conjugates in leukocytes during systemic inflammation. We used genu-
ine monoclonal antibodies against HNE-histidine conjugates for immuno-cytochemical, im-
muno-histochemical and immuno-electronmicroscopical analyses of HNE in inflammatory
cells. Spleen tissue, leukocytes from blood and macrophages from the peritoneum of rats
intraperitoneally (i.p.) injected with micronized zeolite (MZ) were analyzed. HNE-histidine
conjugates were predominantly detected near cell membranes, phagosomes and macrophage
granules. Immunodetection of HNE-histidine conjugates may be used as an analytical immuno-
chemical method to study HNE formation in pathological and physiological processes and for
pathomorphological diagnostic procedures.
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INTRODUCTION
Oxidative stress is a balance shift of oxido-reductive re-
actions to oxidation, resulting in excessive production of
reactive oxygen species (ROS).1 ROS are normally form-
ed in small quantities during metabolic processes.2,3 They
are also intensively produced by phagocytes during in-
flammation as a mechanism of defense against poten-
tially harmful macromolecular agents and cells.4,5 Hy-
droxyl radical is one of the most harmful ROS because
of its high reactivity and instability and it is the only ROS
that has enough energy to cause lipid peroxidation.6,7
Overproduction of ROS is cytotoxic and damages macro-
molecules (DNA, proteins, sugars and lipids).8
During intense oxidative stress ROS damage polyun-
saturated fatty acids (PUFA) causing a chain reaction of
lipid peroxidation, resulting in the destruction of biomem-
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branes. Final products of lipid peroxidation are reactive
aldehydes such as 4-hydroxyalkenals and other similar
,-unsaturated aldehydes that also act as inflammatory
mediators.9,10,11
A great number of these aldehydes have been isolat-
ed from biological samples, where they may promote
and reinforce cell damage induced by oxidative stress.12,
13,14,15,16,17 Lipid-derived aldehydes are more stable than
ROS and can therefore diffuse to targets far from the ini-
tial oxidative injury. Among these aldehydes, of particu-
lar biochemical and biomedical relevance is 4-hydroxy-
2-nonenal (HNE), denoted the »second toxic messenger
of free radicals«.8,18,17
HNE has 3 functional groups: an aldehyde group
(C=O), a carbon-carbon double bond (C=C) and a hydro-
xyl group (OH). Which of these groups will interact with
bioactive macromolecules depends mostly on the reac-
tant and reaction conditions.7 Therefore, HNE directly
reacts mostly with proteins by binding to cysteine, histi-
dine and lysine residues. It can also induce a sequence of
complex biochemical reactions.19,20 At high concentrations
(100 mol dm–3 and more) HNE has acute cytotoxic ef-
fects that usually lead to cell death. Physiological con-
centrations of HNE, in tissues and in serum, are below
or in the range of 1 mol dm–3. Although it is not certain
yet which are the major biological activities of the alde-
hyde under physiological conditions, it seems that growth
modifying activities may dominate.21 Activities of adeny-
late-cyclase, guanylate-cyclase and phospholipase C are
affected by HNE. Thus, HNE is involved in the regula-
tion of cell growth, signal transmission and other impor-
tant cell functions.7 HNE is considered to be one of the
major mediators of oxidative stress,22 a chemotactic al-
dehyde end product of lipid peroxidation,23 a major lipid
peroxidation product,24,25 and a causative factor of secon-
dary tissue damage.2,8,26
In the first 25 years of its history, HNE was deter-
mined only by complex chemical methods (gas chroma-
tography and mass spectroscopy).25 In the 1990s, several
polyclonal and monoclonal antibodies against HNE mo-
dified epitopes on proteins were developed, which result-
ed in more experimental studies.
According to the available data, there are 49 papers
that use monoclonal antibodies against HNE conjugated
with proteins, but the use of such antibodies coated with
colloidal gold for immunoelectromicroscopy is very rare
(only three publications).27,28,29
In only one study the authors evaluated the presence
of HNE in inflammatory cells, but they used bacterial
phagocytosis as a model and specific polyclonal antibo-
dies recognizing 4-HNE-protein adducts and gp91-phox
(flavocytochrome b large subunit) in cryofixed, molecu-
lar distillation-dried neutrophils.27
In our study, we used a modified immunogold me-
thod based on monoclonal antibodies for detection of
HNE-histidine conjugates in formalin-fixed cells. In our
experiment, we analyzed spleen tissue, peripheral blood
leukocytes and peritoneal macrophages obtained from rats
challenged i.p. by the application of tribomechanically
micronized zeolites (MZ) that attract macrophages30,31
acting against MZ as a foreign particle (unspecific im-
munogen).
Zeolites are hydrated natural and synthetic micropo-
rous crystals with structures containing SiO4 and AlO4
tetrahedral and linked by shared oxygen atoms.32 Zeoli-
tes possess many biological properties as well as long-
term chemical and biological stability.33 After i.p. appli-
cation of MZ, the number of peritoneal macrophages, as
well as their production of superoxide anions, was seven
times higher than in control mice.34 However, NO gen-
eration was totally abolished. At the same time, translo-
cation of p65 (NFkB subunit) to the nucleus of splenic
cells was observed. There was no change in the concen-
tration of liver TBARS (thiobarbituric acid-reactive sub-
stances) and spleen TSA (lipid-bound sialic acid), indicat-
ing that MZ does not have systemic pro-oxidative effects.
This was important for our study aimed at verifying the
specificity of the immunoelectronmicroscopy method of
detecting intracellular HNE-histidine adducts.
EXPERIMENTAL
Animals and Treatment
Three months old male Wistar rats of an average weight of
300 g were used with water and food given ad libitum. The
animals (N = 7) were injected i.p. with 3 mg of MZ in 0.3
ml of Hank’s solution and were kept individually in plastic
cages under standard conditions (regulated air atmosphere,
12 hours day/night cycle) for 24 hours until they were sacri-
ficed by ether. Rats were used for isolation of macrophages,
leukocytes and spleen tissue.
Fine powder of natural clinoptilolites (MZ: micronized
zeolite) from Slovakia was obtained by tribomechanical mi-
cronization.31 Particle size analysis of the clinoptilolite show-
ed that the maximum particle frequency appeared at 1 µm.
Processing of Cells and Tissues
Macrophages, leukocytes and spleen tissue were collected
under sterile conditions from each animal separately.
Macrophages were collected from the peritoneal cavity
of rat 24 hours after i.p. administration of MZ (15 mg/rat).
Cells were collected with sterile PBS (phosphate buffered
saline, pH = 7.2), after mechanical provocation of the peri-
toneum. Macrophages were washed by centrifugation at
1100 rpm for 5 minutes at +4 °C and used for the analysis.
Leukocytes were isolated from blood taken from the
heart with a heparinized syringe and placed into a heparin
coated tube. Blood was allowed to settle for two hours;
thus, the erythrocytes were on the bottom of the tube and
leukocytes formed a white ring on the top of the erythro-
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cyte pellet. Leukocytes from the top were collected, diluted
in PBS and used for the analysis. According to the trypan
blue exclusion assay, viability of the cells was >98 %.
Spleen tissue was isolated under sterile conditions, dis-
sected into small pieces (<1 mm3), left in PBS for 30 min
and used in the experiment.
4-Hydroxynonenal Preparation
The aldehyde, in the form of 4-hydroxy-2-nonenal-dimethyl-
acetal (HNE-DMA) was kindly provided by the Institute of
Molecular Biology, Biochemistry and Microbiology, Graz,
Austria. Prior to the experiment, it was activated with 1
mmol dm–3 HCl (Kemika, Croatia) for 1 hour. The concen-
tration of HNE was spectrophotometrically determined
(Biochrom 4060, LKB Pharmacia, USA). For the experi-
ment, HNE was diluted in the DMEM medium (Dulbecco’s
Modified Eagle’s Medium).
HNE Treatments in vitro
Blood leukocytes and peritoneal macrophages (7  107 in
2 ml), treated in vitro with 100 mol dm–3 HNE for 30 min
at 37 °C, were taken as HNE-positive control samples. Very
small spleen tissue pieces (1 mm3) were also treated in vitro
with 100 mol dm–3 HNE for 30 min at 37 °C, and were
taken as HNE-positive control samples. The untreated sam-
ples were left, in the same condition, in plain DMEM me-
dium. Afterwards, the samples were fixed in a 10 % buffered
formalin solution for immunohistochemistry and immuno-
cytochemistry, and in a mixture of glutaraldehyde/para-
formaldehyde in cacodylate buffer for immunoelectronmi-
croscopy.
Immunohistochemical and Immunocytochemical De-
tection of HNE
For immunostaining, slides were treated as described be-
fore, and specific monoclonal antibodies provided by Karl-
-Franzen’s University in Graz, Institute of Molecular Biol-
ogy, Biochemistry and Microbiology, Graz, Austria were
applied.17,35
Monoclonal antibodies for the detection of HNE-modi-
fied proteins were obtained from the culture medium of the
clone »HNE 1g4«, produced by a fusion of Sp2-Ag8 mye-
loma cells with B-cells of a BALBc mouse immunized with
HNE modified keyhole limpet hemocyanine. The antibody
is specific for the HNE-histidine epitope in HNE-protein
(peptide) conjugates and gives only 5 % cross reactivity
with HNE-lysine and 4 % with HNE-cysteine.36
For the immunocyto/histochemical detection of HNE-
-adducts, the immunoperoxidase (peroxidase labeled anti-
-peroxidase antibodies, PAP) technique was used, with sec-
ondary rabbit-anti-mouse antibodies (Dako, Denmark), ap-
plied on 5 m sections of the formalin-fixed paraffin
embedded sections of the samples. 3,3'-Diaminobenzidine
tetrahydrochloride (DAB, Sigma, USA) was used as chro-
mogen. The PAP-DAB staining indicated the presence of
HNE as brown staining while no contrast-staining was used.
Specificity of anti-HNE immunostaining was routinely
validated as described before35,37 using HeLa cells pretreated
with ranging concentrations of HNE (1–100 mol dm–3).
Immunoelectronmicroscopical Detection of HNE
(Immunogold Method)
Samples fixed in a mixture of glutaraldehyde/paraformalde-
hyde in cacodylate buffer (pH = 7.2) were first infiltrated
with epoxy resin. Ultrathin sections (130 Å) were cut with
a diamond knife on a Reichert ultramicrotom. Sections were
mounted directly onto 200 mesh nickel grids. For immuno-
staining, endogenous peroxidase activity was blocked and
osmium was washed off the sections with 3 % hydrogen
peroxide in PBS, which makes the sections more hydrophi-
lic. Murine monoclonal antibodies against HNE-histidine
conjugates described before were used as the primary anti-
body diluted 1:10 in 1 % bovine serum albumin (BSA,
Hamosan, Graz, Austria). The samples were incubated for
24 hours at +4 °C. The secondary antibody was a colloidal
gold coated rabbit-anti-mouse immunoglobulin of 10 nm
(Dako, Denmark) diluted in PBS (1:50). After immunola-
beling, sections were counterstained with uranyl acetate
(Agar, England) and Reynolds lead nitrate solution, and af-
terwards grids were analyzed by electron microscopy (Mor-
gagni 268D, Philips).
RESULTS
Analysis of HNE-histidine Adducts Distribution by
Light Microscopy
In control peripheral blood leukocytes, HNE positivity
(determined by the PAP method) was hardly noticed and
was present in only a few cells (Figure 1 a1). It was mos-
tly located adjacent to the cellular membranes. In con-
trast, in most of the peripheral blood leukocytes treated
with 100 mol dm–3 HNE, very evident imunocytoche-
mical HNE positivity was observed, mostly in cell mem-
branes (Figure 1 b1). Macrophages isolated from rat pe-
ritoneum showed results similar to blood leukocytes.
HNE-untreated macrophages showed moderate HNE po-
sitivity near the cell membranes in some cells (Figure 1 a2),
while macrophages that were treated with 100 mol dm–3
HNE showed marked immunopositivity, particularly in
the cell membrane region (Figure 1 b2).
HNE-immunopositivity was seen in only some spleen
cells in the tissue that was not treated with HNE (Fig-
ure 1 a3), while in vitro treatment of spleen tissue with
100 mol dm–3 HNE resulted in remarkable immunopo-
sitivity (Figure 1 b3).
Analysis of HNE-histidine Adducts Distribution by
Electron Microscopy
Ultrastructural analysis showed similar HNE-histidine
adducts distribution in untreated blood leukocytes, peri-
toneal macrophages and spleen tissue cells. Samples that
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were not treated with 100 mol dm–3 HNE had better
preserved cell structures and moderate HNE positivity
marked by 10-nm colloidal gold particles. HNE-histidi-
ne conjugates were detected inside their mitochondria, near
phagosomes and membrane structures, beside macro-
phage granules or attached to the cellular membrane, but
were rarely present in the cytosol or the nuclei (Figure 2
a1, a2, a3). HNE-untreated leukocytes (Figure 2 a1) had
occasionally HNE positivity while membrane structures
were intact. Macrophages that were not treated with HNE
(Figure 2 a2) had seldom HNE-histidine adducts in cyto-
sol and in granules, which were of well preserved struc-
ture. Similarly, HNE-untreated spleen tissue (Figure 2 a3)
showed occasional presence of HNE-immunopositivity in
cytosol and in the vicinity of the nucleus, with preserved
integrity of the cellular organelles and the nucleus.
Ultrastructural analysis of leukocytes, macrophages
and spleen tissues that were treated with 100 mol dm–3
HNE showed very evident HNE-positivity beside ma-
crophage granules, near and on membrane structures and
diffusely spread in the cytoplasm. Samples treated with
100 mol dm–3 HNE had slightly damaged cytoplasmic
structures (Figure 2 b1, b2, b3). HNE-treated samples of
leukocytes (Figure 2 b1) showed remarkable HNE-histi-
dine positivity mostly on damaged membrane structures
and in the vicinity of cellular membranes in the cytoplasm.
Macrophages (Figure 2 b2) treated with HNE showed HNE
positivity around cytoplasmic granules, which were also
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Figure 1. (a.) HNE positivity detection by the imunocytochemical PAP method in HNE-untreated samples; (a1) leukocytes from blood
(magnified 400 ), (a2) macrophages (magnified 400 ), (a3) spleen tissue (magnified 200 ); (b.) HNE positivity detection by the imuno-
cytochemical PAP method in samples treated with 100 mol dm–3 HNE; (b1) leukocytes (magnified 400 ), (b2) macrophages (magnified
400 ), (b3) spleen tissue (magnified 200 ).
damaged. Similarly, the spleen tissue (Figure 2 b3) used
as HNE-positive control showed very prominent positi-
vity in cytosol and around damaged membrane structu-
res and the nucleus.
DISCUSSION
Since HNE is known as a second messenger of free radi-
cals that interferes with cytokines, studying its role in in-
flammation is particularly interesting. The advantage of
our immunodetection method, where genuine monoclo-
nal antibodies raised against HNE-histidine adducts were
used, is that biologically inactive HNE-glutathione con-
jugates are not recognized. Namely, HNE is mostly sca-
venged by binding to the cystein SH-group of glutathione
(GSH), so there is no interaction with HNE-histidine
conjugates analyzed.
It was observed that HNE-histidine conjugates could
be detected by the standardized immunohistochemical
PAP method, but the immunogold method was introduc-
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Figure 2. (a.) Electron microscopic analysis of HNE-untreated samples (marked by 10-nm colloidal gold particles): (a1) peripheral blood
leukocytes had occasionally HNE positivity while membrane structures were intact (magnified 89 000 ), (a2) peritoneal macrophages had
seldom HNE-histidine adducts in cytosol and in granules, which were of well preserved structure (magnified 89 000 ), (a3) spleen tissue
showed occasional presence of HNE immunopositivity in cytosol and in the vicinity of the nucleus, with preserved integrity of the cellular
organelles and the nucleus (magnified 110 000 ); (b.) Electron microscopical analysis of HNE positive control samples: (b1) peripheral
blood leukocytes showed remarkable HNE-histidine positivity mostly in damaged membrane structures and in the vicinity of cellular mem-
branes in the cytoplasm (71 000 ), (b2) peritoneal macrophages showed HNE positivity around cytoplasmic granules, which were also
damaged (magnified 71 000 ), (b3) spleen tissue showed very prominent positivity in cytosol and around damaged membrane structures
and the nucleus (magnified 36 000 x).
ed because we wanted to determine, as far as possible,
the exact location of HNE-histidine conjugates within the
cells, i.e., on particular cellular structures. HNE-histidine
conjugates were clearly visible on electron microscopic
images. These were apparently stable HNE-conjugates
that were not washed out during mechanical and chemi-
cal treatments of cells and tissue samples, as it would be
the case with HNE-GSH adducts.
HNE-histidine conjugates were occasionally detect-
ed in HNE-untreated macrophages, leukocytes and spleen
tissue. Similar findings were also observed for various
rat and human tissues (data not presented), indicating
that this is not a histo- or species-specific finding and is
not related to the MZ treatment in vivo. Since HNE-his-
tidine conjugates were mostly found in phagosomes, mi-
tochondria and cell membranes of leukocytes and ma-
crophages, it is possible that these are the formation sites
of HNE-protein adducts. This may also suggest the pres-
ence of higher amounts of particular HNE-binding pro-
teins in these cellular organelles.
The highest onset of oxidative stress is usually ex-
tracellular or in peroxisomes where peroxidases and
nonenzymatic processes of oxidative PUFA degradation
cause HNE formation. Therefore, HNE positivities de-
tected in the cells should correspond to the HNE-protein
conjugates developed during oxidative burst. Interestin-
gly, most of HNE positivity was localized at the mem-
branes, even if the aldehyde was added exogenously (for
positive controls), indicating a relatively high incidence
of HNE-binding proteins with histidine within and near
the membranes. This might be also relevant to the regu-
lation of cellular activity under oxidative stress or oxida-
tive burst. Namely, we used a relatively high concentra-
tion of HNE (100 mol dm–3 HNE) to get HNE-immuno-
positive staining of the cells, which we had previously
found to increase the growth of lymphocytes in vitro, in-
hibiting the growth of leukemic cells in parallel.38 In our
current study, the same amount of aldehyde was associat-
ed with only moderate changes of the subcellular struc-
tures of leukocytes but with obvious immunopositivity
of the HNE-histidine adducts.
As it is known that HNE can act as a chemoattrac-
tant,23 we can assume that the production of HNE was
not an accidental event, but an inflammation regulating
one. We assume that MZ did not increase the HNE pro-
duction in macrophages and lymphocytes from blood
and spleen of MZ treated rats, although it strongly (se-
ven fold) increased accumulation of macrophages in the
peritoneum.34 Namely, we found that MZ selectively re-
duced generation of HNE in vivo in tumor stroma (nor-
mal cells within the tumor tissue) after Doxorubicin
treatment, leavin the onset of lipid peroxidation intact in
malignant cells.39 Therefore, the absence of HNE in the
control, HNE-untreated cells was not surprising, irre-
spective of the treatment with MZ.
This is the first study where these particular antibodies
specific for HNE-histidine conjugates were used in an
immunogold method. The sensitivity of the immunogold
method could be stronger if largely hydrophilic unicryl
resin were used. The advantages of unicryl for staining
and labeling lie both in its preservation of tissue struc-
tures and its sectioning characteristics, such that prote-
ins, nucleic acids and macromolecules are presented at
the surface of the sections for subsequent incubations.
A further goal of our research is to analyze biologi-
cal effects of lipid peroxidation products using different
methods, such as microarray evaluation of genome ex-
pression depending on the presence of HNE-histidine
conjugates in inflammatory cells. This could be applied
in pathological cells, such as leukemia and lymphoma
cells, and central nervous system cells damaged by ne-
urodegenerative diseases. Combined evaluation of biolo-
gical effects of HNE and of subcellular distribution of
HNE-protein adducts will increase our understanding of
HNE as a signaling molecule and possibly as a major
bioactive marker of oxidative stress.
Acknowledgements. – Financial support of the Croatian
Ministry of Science, Education and Sports is gratefully ac-
knowledged. The authors express their gratitude to Mrs. Gor-
dana Strunjak for excellent technical support.
ABBREVIATIONS
HNE, 4-hydroxy-2-nonenal
HNE-DMA, 4-hydroxy-2-nonenal-dimethyl-acetal
i.p., intraperitoneal
MZ, micronized zeolite
ROS, reactive oxygen species
PUFA, polyunsaturated fatty acids
PBS, phosphate buffered saline
DMEM, Dulbecco’s Modified Eagle’s Medium
PAP, peroxidase labeled anti-peroxidase
DAB, diaminobenzidine tetrahydrochloride
BSA, bovine serum albumin
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SA@ETAK
Nova metoda za dokazivanje HNE-histidinskih konjugata u {takorskim upalnim stanicama
Morana @ivkovi}, Kamelija @arkovi}, Ljubomir [krinjar, Georg Waeg, Marija Poljak-Bla`i,
Suzana Borovi} [unji}, Rudolf Jörg Schaur i Neven @arkovi}
Oksidacijski stres, stanje prekomjernoga stvaranja reaktivnih kisikovih tvari, bitna je sastavnica razli~itih
bolesti, ali i fiziolo{kih procesa (upala). ^esto je razlika izme|u fiziolo{koga i patolo{koga oksidacijskoga stresa
pojava lipidne peroksidacije i njenih zavr{nih toksi~nih produkata, me|u kojima posebnu ulogu ima 4-hidroksi-
2-nonenal (HNE), reaktivni aldehid koji tvori konjugate s bjelan~evinama. Cilj ovoga istra`ivanja bio je utvrditi
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distribuciju HNE-histidinskih konjugata u leukocitima tijekom nespecifi~ne upalne reakcije. Rabili smo izvorna
monoklonalna protutijela na HNE-histidinski konjugat, za imuno-citokemijsko, histokemijsko i elektronsko-
mikroskopsko dokazivanje HNE-a u upalnim stanicama. Analizirano je tkivo slezene, leukociti iz krvi te makro-
fazi {takora kojima je intraperitonealno injiciran mikronizirani zeolit (MZ). HNE-histidinski konjugati prete`ito
su uo~eni uz stani~ne membrane te pored fagosoma i makrofagnih granula. Imunodetekcija HNE-histidinskih
konjugata mogla bi se stoga rabiti kao analiti~ka imunokemijska metoda za istra`ivanja fiziolo{kih i patolo{kih
procesa te u patomorfolo{kim dijagnosti~kim postupcima.
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